DCTx Incubator - A pathway to innovation driven by purpose

Thyago Ohana
24 Jul 2022
Share article Share

Our UCB Digital Care Transformation (DCTx) team has been working to source the

latest innovations from entrepreneurial businesses across the global digital health

ecosystem - challenging ourselves to uncover breakthroughs in care provision and

delivery. Breakthroughs that can have a major impact in solving some of the biggest

challenges in the lives of people living with severe or chronic diseases. The value that

we will seek to create puts their wellbeing paramount.


We believe the ventures we are working with currently, as well as those we seek to

bring into the program moving forward, can have a real impact on the individual lives

of patients and at scale, they have the potential to impact society and our world.


Our ambitions are bold, but we are proud of and enthused by. This is why one of the

most important criteria of the businesses we want to partner with has to be ambition.

The start-ups currently in the program each have that ambition:


Epihunter solutions apply real-time AI to third-party wearable EEG for real-time digital

interventions - reducing the conditions’ daily life impact while generating real-world

data for better diagnosis, treatment and new therapies.


The company has already created, clinically validated and commercialised a

beachhead for absence epilepsy in Europe & Australasia and is now setting up

co-development collaborations for a future product pipeline of 13 products in epilepsy

and other brain disorders.


The miniature LAB-ON-SKINTM sensing platform developed by the Xsensio team in

Lausanne, Switzerland, allows the detection of small changes in skin biofluids.


A non-intrusive wearable device that can help to detect and predict changes in a

number of disease areas could help both clinicians and patients better manage a

range of conditions and lead to better outcomes for patients.


VRx Medical is an immersive digital therapeutics company founded in California by

Garland Wong and Paul Lafferty. Their mission is to deliver accessible, drug-free,

digital wellness through immersive VR technology.


Bringing together virtual and augmented reality to the fingertips of patients, providing a

wide range of therapies that can integrate into their lifestyles


And finally, PeakProfiling combines voice analytics based on quantitative musicology

of sound patterns with Machine Learning methods. Several clinical studies have

already demonstrated that this technology can serve as a valid predictor of certain

clinical conditions.


Each of these DCTx Incubator participants have the combination of innovation and

drive to see it reach a global market.


To find out more about our incubator, apply to be a part of the program and keep

updated on the latest start-ups taking part, please visit our website on - alternatively, you can contact us via email on